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Abstract
Background: Murine norovirus (MNV) is the most common gastrointestinal pathogen of research mice and can
alter research outcomes in biomedical mouse models of inflammatory bowel disease (IBD). Despite indications that
an altered microbiota is a risk factor for IBD, the response of the murine intestinal microbiota to MNV infection has
not been examined. Microbiota disruption caused by MNV infection could introduce the confounding effects
observed in research experiments. Therefore, this study investigated the effects of MNV infection on the intestinal
microbiota of wild-type mice.
Results: The composition of the intestinal microbiota was assessed over time in both outbred Swiss Webster and
inbred C57BL/6 mice following MNV infection. Mice were infected with both persistent and non-persistent MNV
strains and tissue-associated or fecal-associated microbiota was analyzed by 16S rRNA-encoding gene
pyrosequencing. Analysis of intestinal bacterial communities in infected mice at the phylum and family level
showed no major differences to uninfected controls, both in tissue-associated samples and feces, and also over
time following infection, demonstrating that the intestinal microbiota of wild-type mice is highly resistant to
disruption following MNV infection.
Conclusions: This is the first study to describe the intestinal microbiota following MNV infection and demonstrates
that acute or persistent MNV infection is not associated with major disruptions of microbial communities in Swiss
Webster and C57BL/6 mice.
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Background
Noroviruses are highly prevalent, positive-strand RNA
viruses that infect the gastrointestinal tract of several
mammalian species, including humans [1], mice [2] and
cattle [3]. Murine norovirus (MNV) is the most common
pathogen in biomedical research mice worldwide [4] with
a reported prevalence as high as 64% [5-10]. Following the
discovery of MNV-1 in immunocompromised mice [2],
additional MNV strains have been isolated from laboratory
mice that form one serogroup, despite differences in bio-
logical phenotypes [11]. For example, MNV strains MNV-
4 and CR6 cause persistent infections and viral genomes
are detected in feces and tissues for at least 35 days post
infection (DPI), while MNV-1 causes an acute infection
and no infectious virus is shed by 7 DPI [2,11,12]. Re-
cently, MNV was also identified in wild rodents [13,14].
Genetically, MNV strains are diverse, exhibiting sequence
variation across 23% of the genome [14]. MNV replicates
in macrophages (Mφs) and dendritic cells (DCs) in vitro
[15] and infectious virus is found in vivo in the lamina
propria and Peyer’s patches of the intestine, and mesen-
teric lymph nodes [16,17]. MNV-infected mice show vary-
ing degrees of clinical disease. Wild-type mice show no
overt signs of disease during MNV infection [16,18,19],
while some immunocompromised mouse strains succumb
to lethal infection [2]. MNV can also change research
outcomes in mouse models. MNV-4 alters disease pro-
gression in a mouse model of bacterially-induced inflam-
matory bowel disease (IBD) [20], and infection with the
MNV strain CR6 induced intestinal inflammation resem-
bling Crohn’s disease in mice with a genetically susceptible
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background (ATG16L1) [21]. In the latter case, the ob-
served pathologies were in part dependent on an intact
microbiota. Disruption of the microbiota is common fol-
lowing bacterial infection of the gastrointestinal tract and
is associated with diseases such as IBD and post-infectious
irritable bowel syndrome (see, for example, [22,23]). This
raised the question of whether MNV infection changes
the murine intestinal microbiota. Since this is currently
unknown, our study sought to determine the extent to
which MNV infection disrupts the bacterial community of
the murine intestine.
Inbred and outbred immunocompetent mice were in-
fected with persistent or non-persistent strains of MNV
(MNV-1, MNV-4, CR6). In independent, but complemen-
tary experiments conducted at two institutions, the com-
position of fecal-associated or tissue-associated microbial
communities was determined at various times post infec-
tion by pyrosequence analysis of the bacterial 16S rRNA-
encoding gene amplicons. No major alterations in the
murine intestinal microbiota were detected at the phylum
and family levels in both Swiss Webster and C57BL/6
mouse strains after MNV infection. These results suggest
that the intestinal microbiome of immunocompetent
inbred and outbred mouse models are resistant to MNV
infection. Further studies are needed to determine the
ability of microbial communities to resist MNV disruption
in immunocompromised mice.
Methods
Virus
MNV strain MNV-1 (GV/MNV1/2002/USA), plaque-
isolate CW3 (GenBank accession no. EF014462) [11]
was used at passage 6. MNV strain MNV-4 (GV/MNV4/
2005/US; GenBank accession no. DQ223043), a field iso-
late [12], was used at passage 3. MNV strain CR6 (GV/
CR6/2005/US; GenBank accession no. EU004676) was
plaque purified three times as previously described for
MNV-1 [19] and used at passage 3. Virus lysates were
concentrated by ultracentrifugation and resuspended in
phosphate-buffered saline (PBS) as described previously
[24]. Mock-infected lysates were prepared in a similar
manner and used as controls.
Swiss Webster (outbred strain) infection and sample
collection
Swiss Webster infection studies were performed as two
separate experiments. For both experiments, 7-week-old
male outbred Swiss Webster mice were purchased from
Charles River Laboratories. All mice were seronegative for
MNV at the onset of the experiments. Mice for each ex-
periment were purchased in separate batches and are thus
described separately. Mice were housed at the University
of Michigan animal facilities. Animal studies were per-
formed in accordance with local and federal guidelines as
outlined in the ‘Guide for the Care and Use of Laboratory
Animals’ of the National Institutes of Health. The protocol
was approved by the University of Michigan Committee
on Use and Care of Animals (UCUCA no.: 09710). The
first experiment used nine replicate cages, with three mice
cohoused per cage and per treatment group. Mice were
infected orally with 1 × 107 plaque forming units (pfu) of
MNV-1 (n = 27) in a volume of 25 μl PBS, or mock lysate
(n = 27) as a control. Tissue samples from the distal ileum,
cecum, and colon were collected on days 7, 28, and 56
post infection. Intestinal contents were removed, and half
of the cecum and 1 cm pieces of ileum and colon were
snap frozen and stored at −80°C.
In the second experiment a total of six replicate cages
with three mice cohoused per cage were used per treat-
ment group. Mice were orally infected with 3 × 106 pfu of
either MNV-1 (n = 18) or MNV-4 (n = 18) in a volume of
30 μl PBS or mock lysate (n = 18) as a control. Tissue
samples from the distal ileum, cecum and colon were
collected on days 1 and 3 post infection as described
above. Infection was verified by measuring viral shedding
in fecal pellets collected at the time of tissue harvest by
Charles River Laboratories Research Animal Diagnostic
Services (Wilmington, MA, USA) using quantitative re-
verse transcription real-time polymerase chain reaction
(qRT-PCR) as described previously [11].
DNA extraction (Swiss Webster)
DNA was extracted from murine intestinal tissues using
the Roche MagNA Pure Compact system (Roche Diagnos-
tics GmbH, Mannheim, Germany). Tissue samples were
suspended in a mixture of Roche Bacterial Lysis Buffer
(Roche Diagnostics GmbH, Mannheim, Germany) and
sterile PBS (pH 7.4, Invitrogen, Carlsbad, CA, USA). Tissue
was disrupted by bead-beating for 1 minute, followed by
treatment with 50 μl of proteinase K for 10 minutes at
65°C. Samples were further disrupted by 1 minute of add-
itional bead beating, before heat inactivation at 95°C for
10 minutes. Additional sample processing was performed
on the MagNA pure compact system according to the
Roche MagNA Pure Nucleic Acid Isolation Kit I proto-
col (Roche Diagnostics GmbH, Mannheim, Germany).
Extracted DNA was quantified on a NanoDrop 1000 spec-
trophotometer (NanoDrop, Wilmington, DE, USA) and
stored at −20°C.
Pyrosequencing (Swiss Webster)
Tissue-derived DNA samples were submitted for 16S
rRNA gene amplification and pyrosequencing in two
separate batches at the Human Genome Sequencing
Center at Baylor University College of Medicine in
Houston, TX, USA and the University of Michigan DNA
Sequencing Core in Ann Arbor, MI, USA. The V3 to V5
region of the 16S rRNA gene was amplified following
Nelson et al. Microbiome 2013, 1:7 Page 2 of 11
http://www.microbiomejournal.com/content/1/1/7
the Broad HMP protocol (HMP MDG Default Protocol
v4.2), which can be found at: http://www.hmpdacc.org/
doc/16S_Sequencing_SOP_4.2.2.pdf.
Amplified PCR products were checked for quality on a
2% agarose gel for visual verification, and each sample
was individually quantified using the Quant-It PicoGreen
dsDNA kit (Molecular Probes, Eugene, OR, USA). Each
sample was diluted to normalize concentrations before
pooling. The pooled sample was then checked on a
Bioanalyzer 2100 machine (Agilent, Santa Clara, CA,
USA) using a DNA1000 lab chip (Agilent) to verify sam-
ple purity prior to amplification by emulsion PCR and
pyrosequencing.
C57BL/6 (inbred strain) infection and sample collection
In an independent experiment performed in parallel,
7-week-old male C57BL/6 mice (n = 20), five siblings
from four sets of identified parents, were used. The
mice were bred at Washington University School of Medi-
cine under specific pathogen-free conditions [21] in ac-
cordance with all Federal and University policies. Mice
were divided into four treatment groups with one to two
mice from each sibling group placed into each treatment
group, including untreated control (n = 5), mock infected
control (n = 5), MNV-1 infected (n = 5), and CR6 infected
(n = 5). All mice were singly housed for the duration of
the experiment. All groups except the untreated control
mice were given either sterile PBS (25 μl) for mock infec-
tion, or orally infected using 3 × 107 pfu of CR6. Feces
were collected from each mouse on days 0, 1, 2, 4, 8, 28
and 42 following infection. All mice were seronegative at
the initiation of the experiments and as expected only the
MNV-infected mice were seropositive at the conclusion of
the experiment.
DNA extraction (C57BL/6)
Fresh fecal samples were harvested into sterile screw-top 2
ml tubes containing 500 ml of 0.1 mm zirconia/silica beads
(BioSpec, Bartlesville, OK, USA) and stored at −80°C.
DNA was isolated by phenol-chloroform extraction and
cleaned up using the AMpure (Agencourt, Beckman
Coulter, Inc., Brea, CA, USA) system according to the
manufacturer’s protocol. The DNA was then diluted to a
concentration of 10 to 100 ng/μl.
Pyrosequencing (C57BL/6)
Each DNA sample was setup in triplicate and pooled at
the end of each PCR run to avoid founder effects. The
primers used were described previously [25] and ampli-
fied the V1 to V2 region of the 16S rRNA encoding
gene, with a universal forward primer and a reverse
primer with the addition of a linker and an eight base
pair barcode (27F-TCAGAGTTTGATCCTGGCTCAG,
338R-NNNNNNNNCATGCTGCCTCCCGTAGGAGT).
The DNA was amplified using 5 Prime Hotmastermix
(5Prime Inc., Gaithersburg, MD, USA) with cycling
conditions identical to those published previously [26].
The pooled PCR products were run on an agarose gel to
confirm the generation of a 300 bp product prior to the
submission to the Genome Sequencing Center (GSC) at
Washington University, St Louis, USA, for emulsion
PCR amplification and 454 Pyrosequencing.
Pyrosequencing data processing and analysis
Analysis of all 454 pyrosequencing data was performed
using mothur (version 1.20) [27]. The standard operating
procedure instructions for pyrosequencing data processing
on the mothur website were followed and can be found at:
http://www.mothur.org/wiki/Schloss_SOP.
Pyrosequencing data for both Swiss Webster mouse
experiments were analyzed together, while data from
C57BL/6 mice were analyzed separately. Both data sets
were then processed analogously. First, mothur was used
for assigning operational taxonomic units (OTUs), com-
munity structure comparisons and classification of 16S
rRNA sequences. Classifications were determined by com-
paring sequences to the Ribosomal Database Project
(RDP) (Michigan State University, East Lansing, MI, USA)
[28]. Next, sequences were trimmed to remove any am-
biguous base calls, those with more than 8 homopolymers,
and those with an average quality score below 35 in a
window of 50 nucleotides. After trimming, sequences
were filtered based on size, and all reads less than 194
nucleotides (Swiss Webster data set) or 219 nucleotides
(C57BL/6 data set) were removed. Filtering thresholds
were determined based upon alignment with the silva
alignment database (http://arb-silva.de/) for each data set.
Specifically, during the column alignment, the vertical set-
ting in mothur was set to ‘true’ to remove any column
containing gap characters, and the trump setting was set
to ‘.’, so any column containing a blank nucleotide was also
removed during filtering. Additionally, reads with one or
more ambiguous calls were also removed. Only sequences
containing the reverse primer were used in the analysis.
OTUs were assigned to sequences based on 97% se-
quence identity prior to RDP classification. Classified OTUs
were used to determine the relative abundance of bacterial
phyla in each sample and for statistical comparisons be-
tween samples.
Principal coordinates analysis (PCoA) was used to assess
community similarity among samples by representing the
relative abundance of OTUs in each community using
two different analyses. First, a Yue and Clayton-based dis-
tance matrix [29], which measures community structure
by incorporating both membership and abundance, was
generated. Second, OTU data was analyzed using PCoA
via the Jaccard dissimilary index [30], which measures
only membership. These distances were displayed visually
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in two-dimensional space in PCoA plots. Communities
clustered similarly by tissue site, but not by infection sta-
tus or time, using both Yue and Clayton and Jaccard indi-
ces, thus the latter analysis is not shown.
Non-metric multidimensional scaling (NMDS) was used
to assess community similarity. NMDS-based ordinations
served as a comparator to PCoA to view the data with
reduced distortion due to the horseshoe effect seen in
PCoA. NMDS values were calculated using the NMDS
command in mothur, using all default parameters, and
those values were displayed visually in two-dimensional
space.
Phylotype analysis was performed using relative abun-
dance values for comparison at both the phylum and family
taxonomic levels once relative abundance measurements
were averaged for replicate samples in each tissue and treat-
ment group.
DNA sequences are publically available via MG-RAST.
Swiss Webster mice are available at: http://metagenomics.
anl.gov/linkin.cgi?project=3128. Barcodes for individual
Swiss Webster sequences are included in Additional file 1:
Table S1. C57BL/6 mice sequences are available at http://
metagenomics.anl.gov/linkin.cgi?metagenome=4506745.3.
Barcodes for individual C57BL/6 samples are included in
Additional file 2: Table S2.
Neither study design measured the bacterial density, so
it remains unknown whether MNV infection can raise or
lower overall bacterial densities in the intestine.
Statistical analysis
The relative abundance values of specific bacterial phyla
were compared using both the Kruskal-Wallis test of vari-
ance and the Mann–Whitney U test. Metastats [31], a
statistical test used to determine differentially abundant
features, was used within the mothur bioinformatics pro-
gram to determine significant differences (at P = 0.05) of
specific OTUs in treatment groups based on 3% OTU
definitions. All other statistical analyses were performed
using GraphPad Prism version 5 (GraphPad Software, San
Diego, CA, USA). Measurements of community richness
(Chao and ACE) and diversity (Shannon and inverse
Simpson) were calculated using mothur, and were based
on a 3% OTU definition. ACE richness estimates were
based on an OTU with ten or more individuals in it being
considered abundant. The number of total OTUs was
determined by the sobs calculator in the summary.single
command within mothur. It was also based on a 3% OTU
definition. These values, and richness and diversity
estimates are included in Additional file 1: Table S1 and
Additional file 2: Table S2.
When comparing phylotype abundance in either Swiss
Webster or C57BL/6 mice data, individual timepoints
were combined so comparisons could be made between
treatments. This was done because the communities
were stable over time, both in Swiss Webster and
C57BL/6 mice, and showed little variation throughout
the course of the experiment. Specifically, all times were
combined in order to compare relative abundance of
specific phylotypes between each treatment group. Fur-
thermore, times were also combined for comparison at
the OTU level between each treatment group.
Results
The intestinal microbiome of Swiss Webster mice is not
disrupted by MNV infection
To determine whether MNV infection causes large-scale
changes in the intestinal microbiota of outbred Swiss
Webster mice, two separate experiments were set up
(Figure 1). Short-term alterations in the intestinal micro-
biota in wild-type mice were analyzed in Swiss Webster
mice 1 and 3 days following infection with MNV strains
MNV-1 and MNV-4 or mock lysate (Figure 1A). These
early timepoints represent the peak of viral infection
[2,16]. MNV-4 was included because this strain increased
the severity of disease in a mouse model of IBD [20] and a
change in the microbial community is a risk factor for de-
velopment of IBD [32]. Long-term alterations in the intes-
tinal microbiota after clearance of MNV infection were
analyzed in mice infected with MNV-1, which causes an
acute infection [2,11,12], or mock lysate for 7, 28, and 56
days (Figure 1B). In both experiments, DNA was extracted
from distal ilea, ceca and colons of animals for 16S rRNA
Figure 1 Mouse infection schemata for Swiss Webster mice.
Swiss Webster mice were infected orally in two separate
experiments to determine effects on intestinal tissue-associated
microbial communities. (A) Mice were infected orally with two
murine norovirus (MNV) strains, MNV-1 and MNV-4, and compared
to a mock-infected control. At days 1 and 3 following infection
intestinal tissues were harvested. (B) Mice were infected orally with
MNV-1 or mock lysate and tissues harvested on days 7, 28, and 56
post infection. DPI = days post infection; pfu = plaque forming units.
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gene amplification and barcoded 454 pyrosequencing. A
total of 282 samples were amplified (Additional file 3:
Table S3) generating 1,473,332 total high-quality 16S reads
that were used for community analysis. A summary of
alpha diversity measurements for these samples is shown
in Additional file 1: Table S1.
Measurements of community richness and diversity
were compared between treatment groups (Additional file
4: Table S4). Early (days 1 and 3 post infection) and late
(days 7, 28, and 56 post infection) timepoints were
combined because measurements of diversity and richness
were consistent over time. No differences were seen using
the Kruskal-Wallis test of variance between infected and
control samples within a tissue source for all comparisons
except for the late timepoints with Chao richness mea-
surements in the distal ileum and with Shannon diversity
in the colon (highlighted in Additional file 4: Table S4).
To determine if these significant differences could be
influenced by combining sampling times, specific com-
parisons for each timepoint were performed separately
using the Mann–Whitney U test. No significant differences
were seen in these comparisons. Specifically, MNV-1
infected mice versus mock controls were compared separ-
ately at day 7 post infection (P = 0.3450), day 28 post infec-
tion (P = 0.2319), and day 56 post infection (P = 0.7242)
for the Chao richness in the distal ileum. Shannon diversity
was not different in colon samples at post-infection days 7
(P = 0.6607), 28 (P = 0.0712), and 56 (P = 0.6126). There-
fore, no evidence was found that either MNV-1 or MNV-4
infection alters richness or diversity measurements com-
pared to mock-infected controls in Swiss Webster mice in
any tissue examined.
To visualize the relationship among communities, prin-
cipal coordinates analysis (PCoA) was performed on the
OTU diversity data (Figure 2). Similar communities are
located close to one another in the plot, while divergent
communities are located further apart. At both early
(Figure 2A) and late timepoints (Figure 2B), communities
were distinguished according to the tissue site using both
Yue and Clayton (Figure 2) and Jaccard indices (data not
shown). The most divergent communities were found in
the distal ileum, which were dominated by unclassi-
fied Clostridaceae. The cecum was largely defined by
Barnsiella, while the colon was mostly predominated by
Mucispirillum. However, there was no apparent clustering
that separated the communities between infected and un-
infected mice, and the community structure over the
course of the experiment was very consistent and driven
by a predominance of Barnsiella, Alistipes, Mucispirillum,
and unclassified Clostridaceae. Thus, infection did not
alter the bacterial community structure in tissue-associated
communities, suggesting that MNV infection had no ef-
fect (either direct or indirect) on the bacterial micro-
biota. In addition, an ordination was performed using
non-metric multidimensional scaling on this data to ac-
count for the spatial interrelationships of the data points
(Additional file 5: Figure S1). Because of similarities in
community structure over time, these are shown with
all times combined in experiments from either the early
or late timepoints. This analysis confirmed the observed
differences in communities by tissue site and lack thereof
by infection status.
Sequences of representative OTUs were compared to
known sequences in the database to determine the bacter-
ial classification at the phylum and family levels (Figure 3).
Microbial communities were dominated by Bacteriodetes,
Deferribacteres, and Firmicutes. Relative abundance of
each major phyla were compared between infected and
control groups. Significant differences were only detected
at early timepoints (days 1 and 3) in the cecum for
Deferribacteres (P = 0.0135), and in the colon for
Bacteriodetes (P = 0.0073) and Firmicutes (P = 0.0032),
when comparing MNV-1 to mock-infected mice using
the Mann–Whitney U test. There were no significant
differences in the detection of these sample phyla between
infected and control groups in the same tissue at later
timepoints. In addition, the strain of MNV used also did
not affect phylum level detection in any tissue examined
for either early or late timepoints. The major difference
seen between communities was based upon the tissue
source, with cecum and colon being more similar than
distal ileum. When compared broadly, the levels of
Bacteriodetes, Firmicutes, and Deferribacteres were signifi-
cantly different in the distal ileum compared to either the
cecum or colon (P <0.0001) as measured by the Kruskal-
Wallis test.
To determine whether MNV infection caused major
alterations in bacterial communities at the genus level, the
ten most frequently detected genera were compared for
early timepoints (MNV-1 vs mock, MNV-4 vs mock, and
MNV-1 vs MNV-4) and late timepoints (MNV-1 vs mock)
using the Kruskal-Wallis test with Dunn’s multiple com-
parisons. No comparison of infected versus control in the
same tissue was significantly different at either early or
late timepoints. Furthermore, no differences were detected
when comparing MNV-1 versus MNV-4 infected animals
within each tissue. Next, the 25 most abundant OTUs in
Swiss Webster mice were examined for differences be-
tween infected and uninfected groups by metastats. Only
5 of 225 comparisons had significantly different detection
(highlighted in Additional file 6: Table S5). In both of
these analyses all timepoints were combined because
communities were consistent over time. These data indi-
cate that a small fraction of specific OTUs had differences
in relative abundance. However, the biological significance
of these differences is unclear.
In summary, while finer-scale comparisons on the fam-
ily, genus, or OTU level indicated a few minor alterations
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of unclear biologic significance between infected and con-
trol communities, no large-scale alterations in the bacterial
microbiota were seen following MNV infection. Analysis at
the phylum level demonstrated major differences in com-
munity composition by tissue site and a largely unchanged
intestinal tissue-associated microbiota following MNV in-
fection in Swiss Webster mice.
The microbiome of C57BL/6 mice is resistant to
disruption by MNV
To determine whether MNV infection was able to alter the
fecal microbial community, a separate, but complementary
experiment was performed in parallel. In this experiment,
C57BL/6 mice were infected with MNV-1 and CR6
(Figure 4). CR6 was included since this strain, but not
MNV-1, induces a Crohn’s disease-like phenotype in a
microbiota-dependent manner in genetically susceptible
Atg16L1HM mice (on the C57BL/6 background) [21]. As
controls, mice were either mock infected or left untreated.
Feces were collected at multiple timepoints for DNA ex-
traction, 16S rRNA-encoding gene amplification, and
barcoded pyrosequencing. A total of 106 samples were
sequenced (Additional file 7: Table S6), generating 149,938
high-quality reads for community analysis. A summary of
alpha diversity measurements for C57BL/6 mice is shown
in Additional file 2: Table S2. There were no significant
differences in Shannon diversity (P = 0.7158), inverse
Simpson (P = 0.7546), or Chao richness (P = 0.9955) when
Figure 2 Communities in Swiss Webster mice differ by tissue site but not by infection status. This principal coordinates analysis plot
represents the relative operational taxonomic unit (OTU) abundance in Swiss Webster mice at a 3% definition level, and was generated using a
Yue and Clayton distance matrix. (A) Community structure at early timepoints, days 1 and 3 post infection. (B) Community structure at late
timepoints, days 7, 28, and 56 post infection. Each murine intestinal community is represented by a symbol. Each symbol is colored to represent
the tissue location of the community. Arrows represent the direction where the most frequently detected OTUs influence the location of each
sample. All times were combined for each experiment.
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comparing means between treatment groups using the
Kruskal-Wallis test. Because groups were stable over time,
all timepoints were combined for these comparisons. As
above, the community structure was compared using PCoA
generated from OTU community composition (Figure 5).
No apparent clustering was observed between MNV-
infected and uninfected communities. Infection with either
MNV-1 or CR6 strains also caused no alterations in the
microbiota, and no differences between infected groups
were evident. Phylotype comparisons (Figure 6) further
verified that infection did not alter the intestinal com-
munities on the phylum and family taxonomic level. No
significant changes were seen in the relative abun-
dance of the most common phylum and family level
classifications when comparing infected and uninfected
mice using the Kruskal-Wallis test. Specifically, the
phylum level comparison included Bacteriodetes (P =
0.0693) and Firmicutes (P = 0.3945), while the family-
level comparisons of the nine most frequently clas-
Figure 4 Mouse infection schemata for C57BL/6 mice. C57BL/6
mice were orally infected with either murine norovirus (MNV)-1, CR6,
mock lysate, or left untreated, and fecal samples were collected at
indicated timepoints following infection. DPI = days post infection;
pfu = plaque forming units.
Figure 3 Family level diversity comparisons reveal significant differences by tissue, but not by infection status, in Swiss Webster mice.
Comparisons of bacterial family and phyla are shown across tissues and treatment groups. Relative abundance values for each classification were
calculated for individual replicates, then averaged for comparisons. All timepoints for each experiment were combined. Mock = mock-infected control.
Nelson et al. Microbiome 2013, 1:7 Page 7 of 11
http://www.microbiomejournal.com/content/1/1/7
sified families seen in Figure 6 included unclassified
Bacteriodetes (P = 0.1280), Porphyromonadaceae (P =
0.5811), Clostridiaceae (P = 0.2412), unclassified
Clostridiales (P = 0.5354), Erysipelotrichaceae (P =
0.3612), Lactobacillaceae (P = 0.2177), Lachnospiraceae
(P = 0.4567), Peptostreptococcaceae (P = 0.1150), and
Ruminococcaceae (P = 0.1511). At the genus level, there
were also no significant differences when comparing the
ten most frequently detected genera between all treatment
groups using the Kruskal-Wallis test (data not shown).
Furthermore, there were no significant differences in the
numbers of the top 25 most frequent OTUs detected
when comparing both MNV-1 or CR6 versus either the
untreated or mock infected controls, as determined by
Figure 5 The intestinal microbiota of C57BL/6 mice is not altered by murine norovirus (MNV) infection. This principal coordinates analysis
plot was generated using relative operational taxonomic unit (OTU) abundance data in a Yue and Clayton diversity metric. Each symbol
represents the microbiota of a single stool-associated community from mice infected with either MNV-1 or CR6, or from mock lysate-infected or
untreated controls. In this plot, all timepoints for each treatment group were combined. The arrows indicate the most frequent OTUs detected in
samples and the direction they influence where samples are indicated on the plot.
Figure 6 Phylotype abundance comparisons reveal no significant differences by treatment in C57BL/6 mice. Comparison of the average
relative abundance of family level classification across each treatment group. For each replicate, the relative abundance of each family was
calculated, then averaged for each group. All timepoints were combined for comparison.
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metastats (Additional file 8: Table S7) [31]. Taken together,
these data demonstrated that the fecal microbiota of
C57BL/6 mice is similar between MNV-1-infected and
CR6-infected groups and between infected and uninfected
animals. Furthermore, these data are in agreement with
findings from intestinal tissues of Swiss Webster mice,
which similarly indicated that the microbial communities
are not significantly altered by MNV infection.
Discussion
The microbiome plays an important role in health and
disease, including IBD [33,34]. Some MNV strains cause
inflammatory pathologies in research models of IBD
[20,21]. If MNV infection can alter the murine intestinal
microbiota, this may indirectly change the host response
and cause such confounding effects in experiments.
Therefore, the goal of the current study was to determine
whether MNV infection altered the fecal-associated or
tissue-associated microbiota of outbred or inbred wild-
type mice using pyrosequencing of the bacterial 16S
rRNA-encoding gene.
This study used two separate but complementary experi-
mental designs to examine the response of the murine in-
testinal microbiota to MNV infection. The first study
addressed the impact of MNV infection on tissue-
associated bacterial communities in Swiss Webster mice,
while the second study examined fecal bacterial communi-
ties in C57BL/6 mice. Results from both experiments
demonstrated that the microbial communities in intestinal
tissue or feces of Swiss Webster or C57BL/6 mouse strains
did not exhibit major alterations following MNV infection.
This was true even for the distal ileum, the site of highest
MNV-1 replication [16], indicating that viral replication in
intestinal tissues of wild-type mice does not lead to major,
local disruptions of the microbiota. In analogy, a recent
study demonstrated that MNV titers also are not predictive
of intestinal pathology in wild-type mice [35]. Furthermore,
no large-scale changes in the intestinal microbiota were
seen in the setting of three different MNV strains, includ-
ing CR6 and MNV-4. These strains were hypothesized to
cause disruptions in the microbiota because they were
previously implicated in phenotypic alterations of IBD, a
disease linked to the dysbiosis of the intestinal micro-
biome, and caused a Crohn’s-like disease in a microbiota-
dependent manner [20,21]. One major difference between
the studies is that the disease phenotypes were observed in
genetically altered mouse strains, while the current study
was performed in wild-type mice. Since mouse genotype is
known to influence the make-up of the bacterial commu-
nity in the intestine [36], future studies are needed to ad-
dress whether mouse genotype determines the ability of
MNV infection to alter the intestinal microbiota.
Furthermore, microbiota disruption following MNV
infection may result indirectly from changes in host
physiology (for example, altered gastrointestinal transit
time or increased fluid secretion) due to infection. In case
of the related human norovirus, we recently demonstrated
disruption of the intestinal microbiota in nearly one in five
people with symptomatic human norovirus infection [37].
However, no overt clinical disease was observed in wild-
type mice in the current study or in previous studies
[16,38]. Since MNV infection can cause clinical disease in
immunocompromised mouse models, future studies are
needed to address whether immune status and/or clinical
disease severity contribute to the ability of MNV to alter
the microbiota [20,39].
Additional factors that may be critical in determining
whether enteric virus infections alter the intestinal micro-
biota could be virus dose or the site of viral replication.
We think it is unlikely that virus dose affected the study
outcome since the doses used in this study are similar to
the largest dose previously reported (that is, 3 × 107 pfu/
mouse) [11]. Instead, we hypothesize that the site of virus
replication may be an important determinant of whether a
given enteric virus infection disrupts the intestinal bacter-
ial community. MNV replicates in macrophages and den-
dritic cells but not in intestinal epithelial cells [15,19].
Thus, infected cells are not in contact with the intestinal
bacterial microbiota, potentially resulting in the observed
lack of major alterations in bacterial community and
structure.
The results in the current study did demonstrate dif-
ferences in intestinal communities from different tissue
sites in Swiss Webster mice independent of infection
status, with the bacterial community of the distal ileum
being the most divergent compared to cecum and colon,
which were mostly overlapping. This is similar to previ-
ous studies in which cecum and colon, but not ileum,
were also the most similar sites when comparing bacter-
ial communities in wild-type versus MyD88-deficient
C57BL/6 mice [36]. Similarly, spatial differences are
observed in humans [40] and C57BL/6 gnotobiotic mice
transplanted with human fecal bacteria [41]. Therefore,
our study agrees with previous research showing the
murine intestine harbors different bacterial communities
at different sites along the intestine.
Conclusions
The current study demonstrated that MNV infection with
MNV strains causing acute (MNV-1) or persistent (MNV-4
and CR6) infection does not disrupt the tissue-associated
or fecal-associated bacterial communities of two wild-type
mouse strains, outbred Swiss Webster and inbred C57BL/6.
This is the first study to use pyrosequencing to describe the
intestinal community dynamics following MNV infection,
and the first to demonstrate that the intestinal microbiota
of wild-type mice is largely resistant to MNV infection.
These results suggest that microbiome research using wild-
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type mice may not be affected by MNV infection. How-
ever, further studies are needed to determine the ability of
MNV infection to alter microbial communities in mice
with different genetic backgrounds.
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